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Accepted 22 April 2011Adenoid cystic carcinoma (ACC) originating from Bartho-
lin’s gland is a rare carcinoma of the female reproductive tract,
accounting for <1% of all female genital malignancies and
only 0.1e7% of all vulvar carcinomas [1]. Histologically, ACC
comprises only 15% of the many diverse Bartholin’s gland
tumors. Ever since the first documentation of ACC by Klob
in 1864, only approximately 350 cases have been reported
[2]. Due to the low incidence, knowledge regarding optimal
management and clinical outcome is limited. This report
describes the diagnosis, treatment and outcome of a patient
with ACC of Bartholin’s gland.
A 53-year-old multiparous, postmenopausal woman pre-
sented to the outpatient department with a painful, palpable,
nodular mass in the left vulvar area which had been growing
for 2 years. Vulvar examination revealed an elevated, firm,
nodular mass measuring approximately 2.5 cm  2.5 cm,
localized in Bartholin’s gland. Pelvic and rectal examination
revealed no abnormalities. Tumor biopsy revealed a cribriform
pattern of tubules and gland-like elements filled with homo-
geneous basophilic mucin (Fig. 1A and 1B). These charac-
teristic features formed the basis for the diagnosis of ACC of
Bartholin’s gland. Subsequent cystoscopy, sigmoidoscopy, and
thoracic radiographs revealed no abnormalities. Abdominal
and pelvic magnetic resonance imaging and whole body bone
scintigraphy were used to evaluate local and distant metas-
tases. There were no abnormal inguinal lymph nodes, except
for some minor local infiltration in the left vulvar area
measuring 3 cm  3 cm (Fig. 2). The patient underwent
radical hemivulvectomy and bilateral inguinalefemoral lym-
phadenectomy. A minimum 2-cm margin of the normal-
appearing skin or mucosa around the tumor was excised.
Pathology of the excised tumor was consistent with the
previous biopsy result. All resection margins were free of
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doi:10.1016/j.tjog.2012.01.026without any complications. She remained tumor-free for 3
years after the operation.
The original diagnostic criteria for Bartholin’s gland tumors
were published in 1887 by Honan. The strict criteria did not
correlate well with findings of advanced tumors [3]. Thus, in
1972, Chamlian and Taylor from the Armed Forces Institute of
Pathology re-established the diagnostic criteria for Bartholin’s
gland carcinoma [4]. Histologically, areas of transition from
normal to neoplasia must be found; the tumor must be
compatible with Bartholin gland’s origin; and no evidence of
other primary tumor should be identified.
ACC of Bartholin’s gland is a rare vulvar malignancy that is
often disregarded as either a cyst or inflammation. There is
a tendency for local perineural invasion, which is perhaps the
cause for the initial infection-like itch and pain. The ambiguous
symptoms of ACC lead to the delay in both diagnosis and
treatment. The average age of ACC patients is 49 years old
(range: 25e80 years). Bartholin’s gland ACC should be
considered in patients of this age with lesions near the gland [1].
Due to the lack of large case series, no consensus regarding
the optimal treatment of ACC has been established. In most
cases, one of two types of surgical procedure are generally
performed: simple excision and radical vulvectomy, either
with or without lymph node dissection. A review of the
literature suggests that there is a higher recurrence rate in
patients undergoing simple excisions compared with patients
undergoing radical vulvectomy, (69% vs. 43%, respectively)
[5]. It is a common belief that the most important aspect of
treatment is to obtain tumor-free surgical margins to prevent
recurrence; however, Yang et al have found a similar recur-
rence rate in patients with positive (52.9%) and negative
(52.1%) margins [5]. This finding implies that the status of the
margins might not be as important as previously thought.
Postoperative adjuvant radiotherapy has been shown to be
effective in controlling the disease in patients with positive
margins and local recurrences [6].
The benefits of performing either unilateral or bilateral
inguinalefemoral lymphadenectomy remain controversial incs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Microscopic features of perineal biopsy showing the tumor has a cribriform pattern with the lumens containing basophilic mucin (hematoxylin and eosin,
A: 100, B: 400).
120 T.-L.C. Hwang et al. / Taiwanese Journal of Obstetrics & Gynecology 51 (2012) 119e120the treatment of ACC; however, the main determinant of
survival of ACC patients is the status of the inguinalefemoral
lymph nodes [7]. Leuchter et al have reported a 5-year survival
of 52%, 36% and 18% with zero, one or multiple positive
lymph nodes, respectively [8]. With these results in mind, and
the fact that contralateral inguinal node involvement increases
with lesion size, some surgeons prefer bilateral lymph node
resection as was performed in the case described here [9].
Bone and lung are the most common sites of distant
metastasis for ACC of Bartholin’s gland. Liver, kidney, and
brain metastasis also occur but less frequently [10]. Informa-
tion concerning the use and effectiveness of chemotherapy in
the treatment of ACC is limited. Several chemotherapeutic
agents have been developed for this disease including various
combinations of adriamycin, dactinomycin, cyclophosphamideFig. 2. Abdominopelvic magnetic resonance imaging shows a soft tissue mass
infiltrated into the left vulvar area (arrow).and methotrexate [5]. Although some reports of chemotherapy
are encouraging, the number of cases is too few for meaningful
conclusions to be drawn. As such, this option was not explored
for the patient described in this report.
ACC of Bartholin’s gland is a rare, vulvar malignancy with
an aggressive and unpredictable biologic behavior. Due to the
small number of reported cases, there is no consensus regarding
standard treatment. Similar to the treatment of patients with
other vulvar cancers, the present report and literature review
suggest that an early diagnosis combined with radical vulvec-
tomy and bilateral inguinalefemoral lymph node dissection
will optimize the patient’s chances of survival [7,8].
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